Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Breast Cancer

About this trial
This is an interventional supportive care trial for Breast Cancer
Eligibility Criteria
Inclusion Criteria: Men and Women; Age 18 or older; Diagnosed with stage 0/1 BCa; Scheduled for a unilateral, segmental mastectomy ± SLND Able to read, write and speak English or Spanish Able to sign a written informed consent and be willing to follow protocol requirements. Exclusion Criteria: Extreme mobility issues that preclude participating in the study Major thought disorders such as schizophrenia or uncontrolled bipolar disorder or PTSD; Low score on Tellegen Absorption Scale (10 or below, a correlate of hypnotic suggestibility) History of chronic opioid use Current pain 2 or above on 0-10 scale Co-mobilities such as uncontrollable diabetes or hypertension Plastic surgery involvement for oncoplastic reconstruction Have undergone chemotherapy, or if surgery is likely greater than 3 hours Patients with hearing loss that could preclude HS facilitation Known allergy to propofol or other medications used during surgery
Sites / Locations
- M D Anderson Cancer Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Group 1
Group 2
Group 3
Participants will receive hypnosedation before and during surgery as well as local anesthesia and pain/nausea medications during surgery
Participants will receive hypnosedation before surgery and standard general anesthesia during surgery.
Participants will receive standard general anesthesia alone. You will not receive hypnosedation.